Novo Nordisk - WACC Analysis

Novo Nordisk (Weighted Average Cost of Capital (WACC) Analysis)



Helpful Information for Novo Nordisk's Analysis

What is the WACC Formula? Analyst use the WACC Discount Rate (weighted average cost of capital) to determine Novo Nordisk's investment risk. WACC Formula = Cost of Equity (CAPM) * Common Equity + (Cost of Debt) * Total Debt. The result of this calculation is an essential input for the discounted cash flow (DCF) analysis for Novo Nordisk. Value Investing Importance? This method is widely used by investment professionals to determine the correct price for investments in Novo Nordisk before they make value investing decisions. This WACC analysis is used in Novo Nordisk's discounted cash flow (DCF) valuation and see how the WACC calculation affect's Novo Nordisk's company valuation.

WACC Analysis Information

1. The WACC (discount rate) calculation for Novo Nordisk uses comparable companies to produce a single WACC (discount rate). An industry average WACC (discount rate) is the most accurate for Novo Nordisk over the long term. If there are any short-term differences between the industry WACC and Novo Nordisk's WACC (discount rate), then Novo Nordisk is more likely to revert to the industry WACC (discount rate) over the long term.

2. The WACC calculation uses the higher of Novo Nordisk's WACC or the risk free rate, because no investment can have a cost of capital that is better than risk free. This situation may occur if the beta is negative and Novo Nordisk uses a significant proportion of equity capital.